JP Morgan Chase’s Spark Therapeutics, Inc. Common Stock ONCE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2019
Q4 | – | Sell |
-499,936
| Closed | -$48.5M | – | 6063 |
|
|
2019
Q3 | $48.5M | Sell |
499,936
-183,079
| -27% | -$18.3M | 0.01% | 966 |
|
|
2019
Q2 | $69.8M | Sell |
683,015
-347,827
| -34% | -$37.5M | 0.01% | 809 |
|
|
2019
Q1 | $117M | Sell |
1,030,842
-1,452,603
| -58% | -$107M | 0.02% | 597 |
|
|
2018
Q4 | $97.2M | Buy |
2,483,445
+155,541
| +7% | +$6.75M | 0.02% | 631 |
|
|
2018
Q3 | $127M | Buy |
2,327,904
+25,337
| +1% | +$1.73M | 0.02% | 594 |
|
|
2018
Q2 | $191M | Sell |
2,302,567
-112,640
| -5% | -$8.69M | 0.04% | 453 |
|
|
2018
Q1 | $161M | Buy |
2,415,207
+175,622
| +8% | +$10.1M | 0.03% | 482 |
|
|
2017
Q4 | $115M | Buy |
2,239,585
+390,597
| +21% | +$28.1M | 0.02% | 588 |
|
|
2017
Q3 | $165M | Buy |
1,848,988
+241,016
| +15% | +$18.3M | 0.04% | 464 |
|
|
2017
Q2 | $96.1M | Buy |
1,607,972
+58,879
| +4% | +$3.29M | 0.02% | 632 |
|
|
2017
Q1 | $82.6M | Buy |
1,549,093
+112,596
| +8% | +$6.68M | 0.02% | 698 |
|
|
2016
Q4 | $71.7M | Buy |
1,436,497
+100,006
| +7% | +$5.36M | 0.02% | 716 |
|
|
2016
Q3 | $80.3M | Sell |
1,336,491
-13,089
| -1% | -$754K | 0.02% | 632 |
|
|
2016
Q2 | $69M | Buy |
1,349,580
+670,360
| +99% | +$28.6M | 0.02% | 698 |
|
|
2016
Q1 | $20M | Buy |
679,220
+86,659
| +15% | +$2.73M | 0.01% | 1336 |
|
|
2015
Q4 | $26.8M | Buy |
592,561
+541,845
| +1,068% | +$28.4M | 0.01% | 1141 |
|
|
2015
Q3 | $2.12M | Sell |
50,716
-39,170
| -44% | -$2.04M | ﹤0.01% | 2709 |
|
|
2015
Q2 | $5.42M | Buy |
89,886
+46,888
| +109% | +$3.1M | ﹤0.01% | 2342 |
|
|
2015
Q1 | $3.33M | Buy |
+42,998
| New | +$2.48M | ﹤0.01% | 2599 |
|